March of Dimes, 1275 Mamaroneck Avenue, White Plains, NY 10605, USA.
Semin Fetal Neonatal Med. 2014 Jun;19(3):177-82. doi: 10.1016/j.siny.2014.01.001. Epub 2014 Feb 20.
Assisted reproductive technologies (ART) using in-vitro fertilization (IVF) account for ∼1% of births in the USA and as much as 3-4% in Europe or Australia. Initially studies involved infants prospectively examined in an early cohort of US births, with salutary results. Later studies began to show the frequency of birth defects to be increased. In meta-analysis, odds ratio was >1.0, with the 95% confidence limit not extending to <1.0. Although ART are associated with a 30% increase in birth defects; subfertile couples achieving pregnancy without ART show a 20% increase. It thus appears that the increase in birth defects is due less, if at all, to ART protocols per se than to the biological perturbations that generated the infertility that necessitated ART to achieve pregnancy. There is consensus that traditional IVF and intracytoplasmic sperm injection (ICSI)/IVF show the same overall risk notwithstanding increased sex chromosome abnormalities in both procedures and increased hypospadias in ICSI. No other organ system seems disproportionately affected. There is no additive risk in ART twins compared with non-ART twins, nor in embryos having been cryopreserved. The increased risk observed had not appeared to dissuade couples from attempting to have their own children.
辅助生殖技术(ART)采用体外受精(IVF),占美国出生人口的约 1%,在欧洲或澳大利亚则高达 3-4%。最初的研究涉及在美国出生的早期队列中前瞻性检查的婴儿,结果是有益的。后来的研究开始显示出生缺陷的频率增加。荟萃分析显示,优势比>1.0,95%置信限不扩展到<1.0。尽管 ART 与出生缺陷增加 30%有关;但未使用 ART 的不孕夫妇怀孕的出生缺陷增加 20%。因此,出生缺陷的增加似乎与其说是由于 ART 方案本身,不如说是由于导致需要 ART 来实现怀孕的生育力生物干扰。尽管两种方法都存在性染色体异常增加和 ICSI 中尿道下裂增加,但传统的 IVF 和胞浆内单精子注射(ICSI)/IVF 显示出相同的总体风险,这已达成共识。在 ART 双胞胎中,与非 ART 双胞胎相比,没有累积风险,冷冻保存的胚胎也没有风险。观察到的风险增加似乎并没有阻止夫妇尝试生育自己的孩子。